MicroTransponder
PrivateLast Round
Series F
Mar 13, 2025
Est. Valuation
$225M
Total Funding Raised
$164.9M
Company Overview
MicroTransponder is a medical technology company that develops nerve stimulation-based therapies aimed at treating stroke rehabilitation, tinnitus, and various neurological conditions.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MicroTransponder Comps
Public and private peers based on sector, stage, and business model.
MicroTransponder Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series F | Mar 13, 2025 | ||||
| Series E | Sep 21, 2022 | ||||
| Series C | Nov 17, 2017 | ||||
| VC Round | Dec 10, 2015 | ||||
| VC Round | Aug 29, 2013 | ||||
Grant | Feb 24, 2010 |
MicroTransponder Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Longitude Capital | Series F |
| The Vertical Group | Series E, Series F |
| UT Horizon Fund | VC Round |
| Action Potential Venture Capital | Series E, Series F |
| U.S. Venture Partners | Series F |
| Osage University Partners | Series E, Series F |
| GPG Ventures | Series E, Series F |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 25, 2025
Medicare payment change announced for Vivistim procedure, improving reimbursement and market access.
- Nov 17, 2025
Cynthia Lucchese joins as an independent director.
MicroTransponder Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
